| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |